DCTH Competitors & Alternatives

Compare Delcath Systems Inc with similar stocks in the same industry

Medical Devices

DCTH

Main Stock
$19.68
-4.23%
Tradestie Score
36
Market Cap
$376.05M
P/E Ratio
133.6
Revenue Growth
70.7%
Analyst Upside
+45.3%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Other Targeted Chemotherapy Delivery
Competitive Moat: None
Core Technology Stack: Percutaneous Hepatic Perfusion, Chemosaturation Therapy
Major Customers 3
oncology hospitals cancer treatment centers interventional radiologists
Critical Suppliers 2
melphalan API providers catheter component manufacturers
Direct Ecosystem Rivals 2

Top Competitors

63 stocks in Medical Devices
Company Price Market Cap P/E Score Action
INMD InMode Ltd. Ordinary Shares
$13.13
-1.09%
$965.84M 10.9 51 Compare
IRMD iRadimed Corporation
$84.43
-1.08%
$895.74M 45.3 39 Compare
BBNX Beta Bionics, Inc. Common Stock
$15.60
-4.99%
$878.53M - 52 Compare
CRMD CorMedix Inc.
$4.92
+5.47%
$862.55M 2.4 53 Compare
TNDM Tandem Diabetes Care, Inc.
$19.11
-4.78%
$838.54M - 38 Compare
AXGN Axogen, Inc. Common Stock
$55.36
-1.03%
$822.24M - 39 Compare
SIBN SI-BONE, Inc. Common Stock
$23.29
-0.64%
$615.62M - 38 Compare
AVNS Avanos Medical, Inc.
$24.99
+0.04%
$530.84M - 49 Compare
VREX Varex Imaging Corporation Common Stock
$18.22
+0.64%
$507.80M 34.3 51 Compare
BFLY Butterfly Network, Inc.
$5.82
-4.36%
$478.31M - 47 Compare

Data updated: Nov 16, 2026 | Industry: Medical Devices (SIC 3841)

63 stocks in this industry